{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:51:06Z","timestamp":1790970666640,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008150","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000},"record-id":"33077"},{"DOI":"10.1002\/14651858.cd008150.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000},"record-id":"33076"},{"DOI":"10.1002\/14651858.cd008150.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T00:00:00Z","timestamp":1337126400000}}],"reference-count":28,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008150.pub3","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T20:20:46Z","timestamp":1336681246000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Coenzyme Q10 for Parkinson's disease"],"prefix":"10.1002","volume":"2012","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[{"name":"Chinese PLA General Hospital; Department of Geriatric Neurology; Fuxing Road 28 Beijing China 100853"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Chinese PLA General Hospital; Department of Geriatric Neurology; Fuxing Road 28 Beijing China 100853"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yan","family":"Zhan","sequence":"additional","affiliation":[{"name":"School of Public Health, Peking University; Centre for Evidence Based Medicine and Clinical Research, Department of Epidemiology and Biostatistics; 38 Xueyuan Road Haidian District Beijing China 100191"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Xia","sequence":"additional","affiliation":[{"name":"National Center for TB Control and Prevention, China CDC; Dept. of Surveilance and Statistics; 155#, Changbai Rd. Changping Dist Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD008150.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease","volume":"341","author":"M\u00fcller","year":"2003","journal-title":"Neuroscience Letters"},{"issue":"10","key":"10.1002\/14651858.CD008150.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD008150.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archneurol.2009.159","article-title":"Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience","volume":"66","author":"Parashos","year":"2009","journal-title":"Archives of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD008150.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease","volume":"64","author":"Storch","year":"2007","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008150.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000250355.28474.8e","article-title":"A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease","volume":"68","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD008150.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2004.05.003","article-title":"Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease","volume":"188","author":"Shults","year":"2004","journal-title":"Experimental Neurology"},{"key":"10.1002\/14651858.CD008150.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0098-2997(97)00008-3","article-title":"Q10 therapy in patients with idiopathic Parkinson's disease","volume":"18 Suppl","author":"Strijks","year":"1997","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1002\/14651858.CD008150.pub3-BIB8|cit8","unstructured":"Parkinson Study Group Effects of Coenzyme Q10 in Parkinson Disease - Phase III"},{"key":"10.1002\/14651858.CD008150.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(97)01192-X","article-title":"Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice","volume":"783","author":"Beal","year":"1998","journal-title":"Brain Research"},{"issue":"6","key":"10.1002\/14651858.CD008150.pub3-BIB10|cit10","first-page":"1065","article-title":"Coenzyme Q10. Review","volume":"72","author":"Bonakdar","year":"2005","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD008150.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.410320721","article-title":"Criteria for diagnosing Parkinson's disease","volume":"32 Suppl","author":"Calne","year":"1992","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008150.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","article-title":"Biochemical functions of coenzyme Q10","volume":"20","author":"Crane","year":"2001","journal-title":"Journal of the American College of Nutrition"},{"issue":"7190","key":"10.1002\/14651858.CD008150.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008150.pub3-BIB14|cit14","article-title":"The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, editors. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163,293-304","author":"Fahn"},{"issue":"1","key":"10.1002\/14651858.CD008150.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2008.09.069","article-title":"The coenzyme Q10 status of the brain regions of Parkinson's disease patients","volume":"447","author":"Hargreaves","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD008150.pub3-BIB16|cit16","author":"Higgins"},{"issue":"4","key":"10.1002\/14651858.CD008150.pub3-BIB17|cit17","first-page":"CD007435","article-title":"Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension","author":"Ho","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1002\/14651858.CD008150.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1210\/en.2003-0163","article-title":"Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease","volume":"144","author":"Horvath","year":"2003","journal-title":"Endocrinology"},{"key":"10.1002\/14651858.CD008150.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pharmthera.2009.07.003","article-title":"Role of coenzyme Q10 in cardiac disease, hypertension and Meniere-like syndrome","volume":"124","author":"Kumar","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1002\/14651858.CD008150.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008150.pub3-BIB21|cit21","first-page":"71","article-title":"Coenzyme Q10: Is There a Clinical Role and a Case for Measurement?","volume":"29","author":"Molyneux","year":"2008","journal-title":"Clinical Biochemistry Reviews"},{"key":"10.1002\/14651858.CD008150.pub3-BIB22|cit22","author":"Neutel"},{"issue":"4","key":"10.1002\/14651858.CD008150.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7150\/ijbs.3.257","article-title":"Enrichment of coenzymeQ10 in plasma and blood cells: defense against oxidative damage","volume":"3","author":"Niklowitz","year":"2007","journal-title":"International Journal of Biological Sciences"},{"key":"10.1002\/14651858.CD008150.pub3-BIB24|cit24","author":"2008"},{"issue":"2","key":"10.1002\/14651858.CD008150.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ana.410420221","article-title":"Coenzyme Q10 levels correlate with the activities of complexes I and II\/III in mitochondria from parkinsonian and nonparkinsonian subjects","volume":"42","author":"Shults","year":"1997","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008150.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2005.02.002","article-title":"Therapeutic role of coenzyme Q10 in Parkinson's disease","volume":"107","author":"Shults","year":"2005","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD008150.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mds.10619","article-title":"Parkinson's prevalence estimated by a state registry","volume":"19","author":"Strickland","year":"2004","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD008150.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic Review of Incidence Studies of Parkinson's Disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Movement Disorders"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008150.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T08:33:54Z","timestamp":1699950834000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008150.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008150.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,16]]}}}